3-57097655-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017563.5(IL17RD):c.2048C>T(p.Ser683Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,601,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017563.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RD | NM_017563.5 | c.2048C>T | p.Ser683Leu | missense_variant | 12/13 | ENST00000296318.12 | NP_060033.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RD | ENST00000296318.12 | c.2048C>T | p.Ser683Leu | missense_variant | 12/13 | 1 | NM_017563.5 | ENSP00000296318 | P1 | |
IL17RD | ENST00000320057.9 | c.1616C>T | p.Ser539Leu | missense_variant | 13/14 | 1 | ENSP00000322250 | |||
IL17RD | ENST00000463523.5 | c.1616C>T | p.Ser539Leu | missense_variant | 12/13 | 1 | ENSP00000417516 | |||
IL17RD | ENST00000469841.5 | n.1985C>T | non_coding_transcript_exon_variant | 12/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000868 AC: 2AN: 230284Hom.: 0 AF XY: 0.00000807 AC XY: 1AN XY: 123956
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1449222Hom.: 0 Cov.: 32 AF XY: 0.0000167 AC XY: 12AN XY: 719494
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.2048C>T (p.S683L) alteration is located in exon 12 (coding exon 12) of the IL17RD gene. This alteration results from a C to T substitution at nucleotide position 2048, causing the serine (S) at amino acid position 683 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at